APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Polynucleotides Injectable

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Polynucleotides Injectable Market Analysis and Forecast 2026-2032

Report ID 173481130227 December 2025190 pages

Choose your research edition.

Industry ResearchPolynucleotides Injectable Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Polynucleotides Injectable Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Polynucleotides Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polynucleotides Injectable Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Polynucleotides Injectable Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Polynucleotides Injectable market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Polynucleotides Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Polynucleotides Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Polynucleotides Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Polynucleotides Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Polynucleotides Injectable include PharmaResearch Products Co., Ltd., Mastelli Srl, Promoitalia Group S.p.A., GUNA S.p.A., Caregen Co., Ltd., Medytox Inc., Suneva Medical, Inc., Euroresearch S.r.l. and Anteis SA (now part of Merz Pharmaceuticals), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Polynucleotides Injectable, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Polynucleotides Injectable, also provides the sales of main regions and countries. Of the upcoming market potential for Polynucleotides Injectable, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Polynucleotides Injectable sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Polynucleotides Injectable market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Polynucleotides Injectable sales, projected growth trends, production technology, application and end-user industry.

Polynucleotides Injectable Segment by Company

PharmaResearch Products Co., Ltd.

Mastelli Srl

Promoitalia Group S.p.A.

GUNA S.p.A.

Caregen Co., Ltd.

Medytox Inc.

Suneva Medical, Inc.

Euroresearch S.r.l.

Anteis SA (now part of Merz Pharmaceuticals)

Hyundai Pharm Co., Ltd.

Regen Biotech, Inc.

Evolus, Inc.

Cleviel

Promedica International

NeoGenesis Co., Ltd.

Polynucleotides Injectable Segment by Type

Eyes

Lips

Forehead

Jawline & Cheekbones

Others

Polynucleotides Injectable Segment by Application

MedSpas

Aesthetic & Cosmetic Centers

Hospitals

Polynucleotides Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polynucleotides Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polynucleotides Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polynucleotides Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Polynucleotides Injectable in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Polynucleotides Injectable manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polynucleotides Injectable sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Polynucleotides Injectable Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Eyes Major Manufacturers Table 3. Lips Major Manufacturers Table 4. Forehead Major Manufacturers Table 5. Jawline & Cheekbones Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Polynucleotides Injectable Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. MedSpas Major Manufacturers Table 9. Aesthetic & Cosmetic Centers Major Manufacturers Table 10. Hospitals Major Manufacturers Table 11. Polynucleotides Injectable Industry Trends Table 12. Polynucleotides Injectable Industry Drivers Table 13. Polynucleotides Injectable Industry Opportunities and Challenges Table 14. Polynucleotides Injectable Industry Restraints Table 15. Global Polynucleotides Injectable Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Polynucleotides Injectable Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Polynucleotides Injectable Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Polynucleotides Injectable Revenue Market Share by Region (2021-2026) Table 19. Global Polynucleotides Injectable Revenue Market Share by Region (2027-2032) Table 20. Global Polynucleotides Injectable Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kt) Table 21. Global Polynucleotides Injectable Sales by Region (2021-2026) & (kt) Table 22. Global Polynucleotides Injectable Sales by Region (2027-2032) & (kt) Table 23. Global Polynucleotides Injectable Sales Market Share by Region (2021-2026) Table 24. Global Polynucleotides Injectable Sales Market Share by Region (2027-2032) Table 25. Global Polynucleotides Injectable Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Polynucleotides Injectable Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Polynucleotides Injectable Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Polynucleotides Injectable Sales Market Share by Manufacturers (2021-2026) Table 29. Global Polynucleotides Injectable Sales Price (USD/t) of Manufacturers (2021-2026) Table 30. Global Polynucleotides Injectable Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Polynucleotides Injectable Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Polynucleotides Injectable Manufacturers, Product Type & Application Table 33. Global Polynucleotides Injectable Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Polynucleotides Injectable by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Polynucleotides Injectable Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Polynucleotides Injectable Revenue Market Share by Type (2021-2026) Table 40. Global Polynucleotides Injectable Revenue Market Share by Type (2027-2032) Table 41. Global Polynucleotides Injectable Sales by Type 2021 VS 2025 VS 2032 (kt) Table 42. Global Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 43. Global Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 44. Global Polynucleotides Injectable Sales Market Share by Type (2021-2026) Table 45. Global Polynucleotides Injectable Sales Market Share by Type (2027-2032) Table 46. Global Polynucleotides Injectable Price by Type (2021-2026) & (USD/t) Table 47. Global Polynucleotides Injectable Price by Type (2027-2032) & (USD/t) Table 48. Global Polynucleotides Injectable Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Polynucleotides Injectable Revenue Market Share by Application (2021-2026) Table 52. Global Polynucleotides Injectable Revenue Market Share by Application (2027-2032) Table 53. Global Polynucleotides Injectable Sales by Application 2021 VS 2025 VS 2032 (kt) Table 54. Global Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 55. Global Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 56. Global Polynucleotides Injectable Sales Market Share by Application (2021-2026) Table 57. Global Polynucleotides Injectable Sales Market Share by Application (2027-2032) Table 58. Global Polynucleotides Injectable Price by Application (2021-2026) & (USD/t) Table 59. Global Polynucleotides Injectable Price by Application (2027-2032) & (USD/t) Table 60. PharmaResearch Products Co., Ltd. Company Information Table 61. PharmaResearch Products Co., Ltd. Business Overview Table 62. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 63. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product Portfolio Table 64. PharmaResearch Products Co., Ltd. Recent Development Table 65. Mastelli Srl Company Information Table 66. Mastelli Srl Business Overview Table 67. Mastelli Srl Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Mastelli Srl Polynucleotides Injectable Product Portfolio Table 69. Mastelli Srl Recent Development Table 70. Promoitalia Group S.p.A. Company Information Table 71. Promoitalia Group S.p.A. Business Overview Table 72. Promoitalia Group S.p.A. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Promoitalia Group S.p.A. Polynucleotides Injectable Product Portfolio Table 74. Promoitalia Group S.p.A. Recent Development Table 75. GUNA S.p.A. Company Information Table 76. GUNA S.p.A. Business Overview Table 77. GUNA S.p.A. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. GUNA S.p.A. Polynucleotides Injectable Product Portfolio Table 79. GUNA S.p.A. Recent Development Table 80. Caregen Co., Ltd. Company Information Table 81. Caregen Co., Ltd. Business Overview Table 82. Caregen Co., Ltd. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Caregen Co., Ltd. Polynucleotides Injectable Product Portfolio Table 84. Caregen Co., Ltd. Recent Development Table 85. Medytox Inc. Company Information Table 86. Medytox Inc. Business Overview Table 87. Medytox Inc. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Medytox Inc. Polynucleotides Injectable Product Portfolio Table 89. Medytox Inc. Recent Development Table 90. Suneva Medical, Inc. Company Information Table 91. Suneva Medical, Inc. Business Overview Table 92. Suneva Medical, Inc. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Suneva Medical, Inc. Polynucleotides Injectable Product Portfolio Table 94. Suneva Medical, Inc. Recent Development Table 95. Euroresearch S.r.l. Company Information Table 96. Euroresearch S.r.l. Business Overview Table 97. Euroresearch S.r.l. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Euroresearch S.r.l. Polynucleotides Injectable Product Portfolio Table 99. Euroresearch S.r.l. Recent Development Table 100. Anteis SA (now part of Merz Pharmaceuticals) Company Information Table 101. Anteis SA (now part of Merz Pharmaceuticals) Business Overview Table 102. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product Portfolio Table 104. Anteis SA (now part of Merz Pharmaceuticals) Recent Development Table 105. Hyundai Pharm Co., Ltd. Company Information Table 106. Hyundai Pharm Co., Ltd. Business Overview Table 107. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product Portfolio Table 109. Hyundai Pharm Co., Ltd. Recent Development Table 110. Regen Biotech, Inc. Company Information Table 111. Regen Biotech, Inc. Business Overview Table 112. Regen Biotech, Inc. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Regen Biotech, Inc. Polynucleotides Injectable Product Portfolio Table 114. Regen Biotech, Inc. Recent Development Table 115. Evolus, Inc. Company Information Table 116. Evolus, Inc. Business Overview Table 117. Evolus, Inc. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Evolus, Inc. Polynucleotides Injectable Product Portfolio Table 119. Evolus, Inc. Recent Development Table 120. Cleviel Company Information Table 121. Cleviel Business Overview Table 122. Cleviel Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Cleviel Polynucleotides Injectable Product Portfolio Table 124. Cleviel Recent Development Table 125. Promedica International Company Information Table 126. Promedica International Business Overview Table 127. Promedica International Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. Promedica International Polynucleotides Injectable Product Portfolio Table 129. Promedica International Recent Development Table 130. NeoGenesis Co., Ltd. Company Information Table 131. NeoGenesis Co., Ltd. Business Overview Table 132. NeoGenesis Co., Ltd. Polynucleotides Injectable Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 133. NeoGenesis Co., Ltd. Polynucleotides Injectable Product Portfolio Table 134. NeoGenesis Co., Ltd. Recent Development Table 135. North America Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 138. North America Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 139. North America Polynucleotides Injectable Sales Price by Type (2021-2026) & (USD/t) Table 140. North America Polynucleotides Injectable Sales Price by Type (2027-2032) & (USD/t) Table 141. North America Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 144. North America Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 145. North America Polynucleotides Injectable Sales Price by Application (2021-2026) & (USD/t) Table 146. North America Polynucleotides Injectable Sales Price by Application (2027-2032) & (USD/t) Table 147. North America Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Polynucleotides Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Polynucleotides Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 151. North America Polynucleotides Injectable Sales by Country (2021-2026) & (kt) Table 152. North America Polynucleotides Injectable Sales by Country (2027-2032) & (kt) Table 153. North America Polynucleotides Injectable Sales Price by Country (2021-2026) & (USD/t) Table 154. North America Polynucleotides Injectable Sales Price by Country (2027-2032) & (USD/t) Table 155. United States Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 156. Canada Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 157. Mexico Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 158. Europe Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 161. Europe Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 162. Europe Polynucleotides Injectable Sales Price by Type (2021-2026) & (USD/t) Table 163. Europe Polynucleotides Injectable Sales Price by Type (2027-2032) & (USD/t) Table 164. Europe Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 167. Europe Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 168. Europe Polynucleotides Injectable Sales Price by Application (2021-2026) & (USD/t) Table 169. Europe Polynucleotides Injectable Sales Price by Application (2027-2032) & (USD/t) Table 170. Europe Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Polynucleotides Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Polynucleotides Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 174. Europe Polynucleotides Injectable Sales by Country (2021-2026) & (kt) Table 175. Europe Polynucleotides Injectable Sales by Country (2027-2032) & (kt) Table 176. Europe Polynucleotides Injectable Sales Price by Country (2021-2026) & (USD/t) Table 177. Europe Polynucleotides Injectable Sales Price by Country (2027-2032) & (USD/t) Table 178. Germany Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 179. France Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 180. U.K. Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 181. Italy Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 182. Russia Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 183. Spain Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 186. Sweden Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 187. Poland Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 188. China Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 189. China Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 190. China Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 191. China Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 192. China Polynucleotides Injectable Sales Price by Type (2021-2026) & (USD/t) Table 193. China Polynucleotides Injectable Sales Price by Type (2027-2032) & (USD/t) Table 194. China Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 195. China Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 196. China Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 197. China Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 198. China Polynucleotides Injectable Sales Price by Application (2021-2026) & (USD/t) Table 199. China Polynucleotides Injectable Sales Price by Application (2027-2032) & (USD/t) Table 200. Asia Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 203. Asia Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 204. Asia Polynucleotides Injectable Sales Price by Type (2021-2026) & (USD/t) Table 205. Asia Polynucleotides Injectable Sales Price by Type (2027-2032) & (USD/t) Table 206. Asia Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 209. Asia Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 210. Asia Polynucleotides Injectable Sales Price by Application (2021-2026) & (USD/t) Table 211. Asia Polynucleotides Injectable Sales Price by Application (2027-2032) & (USD/t) Table 212. Asia Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Polynucleotides Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Polynucleotides Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 216. Asia Polynucleotides Injectable Sales by Country (2021-2026) & (kt) Table 217. Asia Polynucleotides Injectable Sales by Country (2027-2032) & (kt) Table 218. Asia Polynucleotides Injectable Sales Price by Country (2021-2026) & (USD/t) Table 219. Asia Polynucleotides Injectable Sales Price by Country (2027-2032) & (USD/t) Table 220. Japan Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 221. South Korea Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 222. India Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 223. Australia Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Polynucleotides Injectable Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Polynucleotides Injectable Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Polynucleotides Injectable Sales by Type (2021-2026) & (kt) Table 229. SAMEA Polynucleotides Injectable Sales by Type (2027-2032) & (kt) Table 230. SAMEA Polynucleotides Injectable Sales Price by Type (2021-2026) & (USD/t) Table 231. SAMEA Polynucleotides Injectable Sales Price by Type (2027-2032) & (USD/t) Table 232. SAMEA Polynucleotides Injectable Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Polynucleotides Injectable Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Polynucleotides Injectable Sales by Application (2021-2026) & (kt) Table 235. SAMEA Polynucleotides Injectable Sales by Application (2027-2032) & (kt) Table 236. SAMEA Polynucleotides Injectable Sales Price by Application (2021-2026) & (USD/t) Table 237. SAMEA Polynucleotides Injectable Sales Price by Application (2027-2032) & (USD/t) Table 238. SAMEA Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Polynucleotides Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Polynucleotides Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 242. SAMEA Polynucleotides Injectable Sales by Country (2021-2026) & (kt) Table 243. SAMEA Polynucleotides Injectable Sales by Country (2027-2032) & (kt) Table 244. SAMEA Polynucleotides Injectable Sales Price by Country (2021-2026) & (USD/t) Table 245. SAMEA Polynucleotides Injectable Sales Price by Country (2027-2032) & (USD/t) Table 246. Brazil Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 247. Argentina Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 248. Chile Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 249. Colombia Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 250. Peru Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 252. Israel Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 253. UAE Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 254. Turkey Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 255. Iran Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 256. Egypt Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Polynucleotides Injectable Distributors List Table 260. Polynucleotides Injectable Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Polynucleotides Injectable Image Figure 2. Global Polynucleotides Injectable Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polynucleotides Injectable Market Size Share 2021 VS 2025 VS 2032 Figure 4. Eyes Image Figure 5. Lips Image Figure 6. Forehead Image Figure 7. Jawline & Cheekbones Image Figure 8. Others Image Figure 9. Global Polynucleotides Injectable Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Polynucleotides Injectable Market Size Share 2021 VS 2025 VS 2032 Figure 11. MedSpas Image Figure 12. Aesthetic & Cosmetic Centers Image Figure 13. Hospitals Image Figure 14. Global Polynucleotides Injectable Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Polynucleotides Injectable Revenue (2021-2032) & (US$ Million) Figure 16. Global Polynucleotides Injectable Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Polynucleotides Injectable Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Polynucleotides Injectable Revenue Market Share by Region (2021-2032) Figure 19. Global Polynucleotides Injectable Sales (2021-2032) & (kt) Figure 20. Global Polynucleotides Injectable Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 21. Global Polynucleotides Injectable Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Polynucleotides Injectable Sales YoY (2021-2032) & (kt) Figure 23. Europe Polynucleotides Injectable Sales YoY (2021-2032) & (kt) Figure 24. China Polynucleotides Injectable Sales YoY (2021-2032) & (kt) Figure 25. Asia (Excluding China) Polynucleotides Injectable Sales YoY (2021-2032) & (kt) Figure 26. South America, Middle East and Africa Polynucleotides Injectable Sales YoY (2021-2032) & (kt) Figure 27. Global Polynucleotides Injectable Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Polynucleotides Injectable Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Polynucleotides Injectable Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Polynucleotides Injectable Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Polynucleotides Injectable Revenue Market Share by Type (2021-2032) Figure 33. Global Polynucleotides Injectable Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 34. Global Polynucleotides Injectable Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Polynucleotides Injectable Sales Market Share by Type (2021-2032) Figure 36. Global Polynucleotides Injectable Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Polynucleotides Injectable Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Polynucleotides Injectable Revenue Market Share by Application (2021-2032) Figure 39. Global Polynucleotides Injectable Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 40. Global Polynucleotides Injectable Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Polynucleotides Injectable Sales Market Share by Application (2021-2032) Figure 42. North America Polynucleotides Injectable Revenue Share by Type (2021-2032) Figure 43. North America Polynucleotides Injectable Sales Share by Type (2021-2032) Figure 44. North America Polynucleotides Injectable Revenue Share by Application (2021-2032) Figure 45. North America Polynucleotides Injectable Sales Share by Application (2021-2032) Figure 46. North America Polynucleotides Injectable Revenue Share by Country (2021-2032) Figure 47. North America Polynucleotides Injectable Sales Share by Country (2021-2032) Figure 48. Europe Polynucleotides Injectable Revenue Share by Type (2021-2032) Figure 49. Europe Polynucleotides Injectable Sales Share by Type (2021-2032) Figure 50. Europe Polynucleotides Injectable Revenue Share by Application (2021-2032) Figure 51. Europe Polynucleotides Injectable Sales Share by Application (2021-2032) Figure 52. Europe Polynucleotides Injectable Revenue Share by Country (2021-2032) Figure 53. Europe Polynucleotides Injectable Sales Share by Country (2021-2032) Figure 54. China Polynucleotides Injectable Revenue Share by Type (2021-2032) Figure 55. China Polynucleotides Injectable Sales Share by Type (2021-2032) Figure 56. China Polynucleotides Injectable Revenue Share by Application (2021-2032) Figure 57. China Polynucleotides Injectable Sales Share by Application (2021-2032) Figure 58. Asia Polynucleotides Injectable Revenue Share by Type (2021-2032) Figure 59. Asia Polynucleotides Injectable Sales Share by Type (2021-2032) Figure 60. Asia Polynucleotides Injectable Revenue Share by Application (2021-2032) Figure 61. Asia Polynucleotides Injectable Sales Share by Application (2021-2032) Figure 62. Asia Polynucleotides Injectable Revenue Share by Country (2021-2032) Figure 63. Asia Polynucleotides Injectable Sales Share by Country (2021-2032) Figure 64. SAMEA Polynucleotides Injectable Revenue Share by Type (2021-2032) Figure 65. SAMEA Polynucleotides Injectable Sales Share by Type (2021-2032) Figure 66. SAMEA Polynucleotides Injectable Revenue Share by Application (2021-2032) Figure 67. SAMEA Polynucleotides Injectable Sales Share by Application (2021-2032) Figure 68. SAMEA Polynucleotides Injectable Revenue Share by Country (2021-2032) Figure 69. SAMEA Polynucleotides Injectable Sales Share by Country (2021-2032) Figure 70. Polynucleotides Injectable Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Polynucleotides Injectable Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Eyes
  • Lips
  • Forehead
  • Jawline & Cheekbones
  • Others
Applications
  • MedSpas
  • Aesthetic & Cosmetic Centers
  • Hospitals
Companies covered
  • PharmaResearch Products Co., Ltd.
  • Mastelli Srl
  • Promoitalia Group S.p.A.
  • GUNA S.p.A.
  • Caregen Co., Ltd.
  • Medytox Inc.
  • Suneva Medical, Inc.
  • Euroresearch S.r.l.
  • Anteis SA (now part of Merz Pharmaceuticals)
  • Hyundai Pharm Co., Ltd.
  • Regen Biotech, Inc.
  • Evolus, Inc.
  • Cleviel
  • Promedica International
  • NeoGenesis Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Polynucleotides Injectable Market by Type
  3. 1.2.1 Global Polynucleotides Injectable Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Eyes
  5. 1.2.3 Lips
  6. 1.2.4 Forehead
  7. 1.2.5 Jawline & Cheekbones
  8. 1.2.6 Others
  9. 1.3 Polynucleotides Injectable Market by Application
  10. 1.3.1 Global Polynucleotides Injectable Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 MedSpas
  12. 1.3.3 Aesthetic & Cosmetic Centers
  13. 1.3.4 Hospitals
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Polynucleotides Injectable Market Dynamics
  1. 2.1 Polynucleotides Injectable Industry Trends
  2. 2.2 Polynucleotides Injectable Industry Drivers
  3. 2.3 Polynucleotides Injectable Industry Opportunities and Challenges
  4. 2.4 Polynucleotides Injectable Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Polynucleotides Injectable Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Polynucleotides Injectable Revenue by Region
  3. 3.2.1 Global Polynucleotides Injectable Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Polynucleotides Injectable Revenue by Region (2021-2026)
  5. 3.2.3 Global Polynucleotides Injectable Revenue by Region (2027-2032)
  6. 3.2.4 Global Polynucleotides Injectable Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Polynucleotides Injectable Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Polynucleotides Injectable Sales by Region
  9. 3.4.1 Global Polynucleotides Injectable Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Polynucleotides Injectable Sales by Region (2021-2026)
  11. 3.4.3 Global Polynucleotides Injectable Sales by Region (2027-2032)
  12. 3.4.4 Global Polynucleotides Injectable Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Polynucleotides Injectable Revenue by Manufacturers
  2. 4.1.1 Global Polynucleotides Injectable Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Polynucleotides Injectable Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Polynucleotides Injectable Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Polynucleotides Injectable Sales by Manufacturers
  6. 4.2.1 Global Polynucleotides Injectable Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Polynucleotides Injectable Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Polynucleotides Injectable Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Polynucleotides Injectable Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Polynucleotides Injectable Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Polynucleotides Injectable Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Polynucleotides Injectable Manufacturers, Product Type & Application
  13. 4.7 Global Polynucleotides Injectable Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Polynucleotides Injectable Market CR5 and HHI
  16. 4.8.2 2025 Polynucleotides Injectable Tier 1, Tier 2, and Tier 3
5 Polynucleotides Injectable Market by Type
  1. 5.1 Global Polynucleotides Injectable Revenue by Type
  2. 5.1.1 Global Polynucleotides Injectable Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Polynucleotides Injectable Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Polynucleotides Injectable Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Polynucleotides Injectable Sales by Type
  6. 5.2.1 Global Polynucleotides Injectable Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polynucleotides Injectable Sales by Type (2021-2032) & (kt)
  8. 5.2.3 Global Polynucleotides Injectable Sales Market Share by Type (2021-2032)
  9. 5.3 Global Polynucleotides Injectable Price by Type
6 Polynucleotides Injectable Market by Application
  1. 6.1 Global Polynucleotides Injectable Revenue by Application
  2. 6.1.1 Global Polynucleotides Injectable Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Polynucleotides Injectable Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Polynucleotides Injectable Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Polynucleotides Injectable Sales by Application
  6. 6.2.1 Global Polynucleotides Injectable Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Polynucleotides Injectable Sales by Application (2021-2032) & (kt)
  8. 6.2.3 Global Polynucleotides Injectable Sales Market Share by Application (2021-2032)
  9. 6.3 Global Polynucleotides Injectable Price by Application
7 Company Profiles
  1. 7.1 PharmaResearch Products Co., Ltd.
  2. 7.1.1 PharmaResearch Products Co., Ltd. Company Information
  3. 7.1.2 PharmaResearch Products Co., Ltd. Business Overview
  4. 7.1.3 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product Portfolio
  6. 7.1.5 PharmaResearch Products Co., Ltd. Recent Developments
  7. 7.2 Mastelli Srl
  8. 7.2.1 Mastelli Srl Company Information
  9. 7.2.2 Mastelli Srl Business Overview
  10. 7.2.3 Mastelli Srl Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mastelli Srl Polynucleotides Injectable Product Portfolio
  12. 7.2.5 Mastelli Srl Recent Developments
  13. 7.3 Promoitalia Group S.p.A.
  14. 7.3.1 Promoitalia Group S.p.A. Company Information
  15. 7.3.2 Promoitalia Group S.p.A. Business Overview
  16. 7.3.3 Promoitalia Group S.p.A. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Promoitalia Group S.p.A. Polynucleotides Injectable Product Portfolio
  18. 7.3.5 Promoitalia Group S.p.A. Recent Developments
  19. 7.4 GUNA S.p.A.
  20. 7.4.1 GUNA S.p.A. Company Information
  21. 7.4.2 GUNA S.p.A. Business Overview
  22. 7.4.3 GUNA S.p.A. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GUNA S.p.A. Polynucleotides Injectable Product Portfolio
  24. 7.4.5 GUNA S.p.A. Recent Developments
  25. 7.5 Caregen Co., Ltd.
  26. 7.5.1 Caregen Co., Ltd. Company Information
  27. 7.5.2 Caregen Co., Ltd. Business Overview
  28. 7.5.3 Caregen Co., Ltd. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Caregen Co., Ltd. Polynucleotides Injectable Product Portfolio
  30. 7.5.5 Caregen Co., Ltd. Recent Developments
  31. 7.6 Medytox Inc.
  32. 7.6.1 Medytox Inc. Company Information
  33. 7.6.2 Medytox Inc. Business Overview
  34. 7.6.3 Medytox Inc. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medytox Inc. Polynucleotides Injectable Product Portfolio
  36. 7.6.5 Medytox Inc. Recent Developments
  37. 7.7 Suneva Medical, Inc.
  38. 7.7.1 Suneva Medical, Inc. Company Information
  39. 7.7.2 Suneva Medical, Inc. Business Overview
  40. 7.7.3 Suneva Medical, Inc. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Suneva Medical, Inc. Polynucleotides Injectable Product Portfolio
  42. 7.7.5 Suneva Medical, Inc. Recent Developments
  43. 7.8 Euroresearch S.r.l.
  44. 7.8.1 Euroresearch S.r.l. Company Information
  45. 7.8.2 Euroresearch S.r.l. Business Overview
  46. 7.8.3 Euroresearch S.r.l. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Euroresearch S.r.l. Polynucleotides Injectable Product Portfolio
  48. 7.8.5 Euroresearch S.r.l. Recent Developments
  49. 7.9 Anteis SA (now part of Merz Pharmaceuticals)
  50. 7.9.1 Anteis SA (now part of Merz Pharmaceuticals) Company Information
  51. 7.9.2 Anteis SA (now part of Merz Pharmaceuticals) Business Overview
  52. 7.9.3 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product Portfolio
  54. 7.9.5 Anteis SA (now part of Merz Pharmaceuticals) Recent Developments
  55. 7.10 Hyundai Pharm Co., Ltd.
  56. 7.10.1 Hyundai Pharm Co., Ltd. Company Information
  57. 7.10.2 Hyundai Pharm Co., Ltd. Business Overview
  58. 7.10.3 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product Portfolio
  60. 7.10.5 Hyundai Pharm Co., Ltd. Recent Developments
  61. 7.11 Regen Biotech, Inc.
  62. 7.11.1 Regen Biotech, Inc. Company Information
  63. 7.11.2 Regen Biotech, Inc. Business Overview
  64. 7.11.3 Regen Biotech, Inc. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Regen Biotech, Inc. Polynucleotides Injectable Product Portfolio
  66. 7.11.5 Regen Biotech, Inc. Recent Developments
  67. 7.12 Evolus, Inc.
  68. 7.12.1 Evolus, Inc. Company Information
  69. 7.12.2 Evolus, Inc. Business Overview
  70. 7.12.3 Evolus, Inc. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Evolus, Inc. Polynucleotides Injectable Product Portfolio
  72. 7.12.5 Evolus, Inc. Recent Developments
  73. 7.13 Cleviel
  74. 7.13.1 Cleviel Company Information
  75. 7.13.2 Cleviel Business Overview
  76. 7.13.3 Cleviel Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cleviel Polynucleotides Injectable Product Portfolio
  78. 7.13.5 Cleviel Recent Developments
  79. 7.14 Promedica International
  80. 7.14.1 Promedica International Company Information
  81. 7.14.2 Promedica International Business Overview
  82. 7.14.3 Promedica International Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Promedica International Polynucleotides Injectable Product Portfolio
  84. 7.14.5 Promedica International Recent Developments
  85. 7.15 NeoGenesis Co., Ltd.
  86. 7.15.1 NeoGenesis Co., Ltd. Company Information
  87. 7.15.2 NeoGenesis Co., Ltd. Business Overview
  88. 7.15.3 NeoGenesis Co., Ltd. Polynucleotides Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 NeoGenesis Co., Ltd. Polynucleotides Injectable Product Portfolio
  90. 7.15.5 NeoGenesis Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Polynucleotides Injectable Market Size by Type
  2. 8.1.1 North America Polynucleotides Injectable Revenue by Type (2021-2032)
  3. 8.1.2 North America Polynucleotides Injectable Sales by Type (2021-2032)
  4. 8.1.3 North America Polynucleotides Injectable Price by Type (2021-2032)
  5. 8.2 North America Polynucleotides Injectable Market Size by Application
  6. 8.2.1 North America Polynucleotides Injectable Revenue by Application (2021-2032)
  7. 8.2.2 North America Polynucleotides Injectable Sales by Application (2021-2032)
  8. 8.2.3 North America Polynucleotides Injectable Price by Application (2021-2032)
  9. 8.3 North America Polynucleotides Injectable Market Size by Country
  10. 8.3.1 North America Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Polynucleotides Injectable Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Polynucleotides Injectable Market Size by Type
  2. 9.1.1 Europe Polynucleotides Injectable Revenue by Type (2021-2032)
  3. 9.1.2 Europe Polynucleotides Injectable Sales by Type (2021-2032)
  4. 9.1.3 Europe Polynucleotides Injectable Price by Type (2021-2032)
  5. 9.2 Europe Polynucleotides Injectable Market Size by Application
  6. 9.2.1 Europe Polynucleotides Injectable Revenue by Application (2021-2032)
  7. 9.2.2 Europe Polynucleotides Injectable Sales by Application (2021-2032)
  8. 9.2.3 Europe Polynucleotides Injectable Price by Application (2021-2032)
  9. 9.3 Europe Polynucleotides Injectable Market Size by Country
  10. 9.3.1 Europe Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Polynucleotides Injectable Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Polynucleotides Injectable Market Size by Type
  2. 10.1.1 China Polynucleotides Injectable Revenue by Type (2021-2032)
  3. 10.1.2 China Polynucleotides Injectable Sales by Type (2021-2032)
  4. 10.1.3 China Polynucleotides Injectable Price by Type (2021-2032)
  5. 10.2 China Polynucleotides Injectable Market Size by Application
  6. 10.2.1 China Polynucleotides Injectable Revenue by Application (2021-2032)
  7. 10.2.2 China Polynucleotides Injectable Sales by Application (2021-2032)
  8. 10.2.3 China Polynucleotides Injectable Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Polynucleotides Injectable Market Size by Type
  2. 11.1.1 Asia Polynucleotides Injectable Revenue by Type (2021-2032)
  3. 11.1.2 Asia Polynucleotides Injectable Sales by Type (2021-2032)
  4. 11.1.3 Asia Polynucleotides Injectable Price by Type (2021-2032)
  5. 11.2 Asia Polynucleotides Injectable Market Size by Application
  6. 11.2.1 Asia Polynucleotides Injectable Revenue by Application (2021-2032)
  7. 11.2.2 Asia Polynucleotides Injectable Sales by Application (2021-2032)
  8. 11.2.3 Asia Polynucleotides Injectable Price by Application (2021-2032)
  9. 11.3 Asia Polynucleotides Injectable Market Size by Country
  10. 11.3.1 Asia Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Polynucleotides Injectable Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Polynucleotides Injectable Market Size by Type
  2. 12.1.1 SAMEA Polynucleotides Injectable Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Polynucleotides Injectable Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Polynucleotides Injectable Price by Type (2021-2032)
  5. 12.2 SAMEA Polynucleotides Injectable Market Size by Application
  6. 12.2.1 SAMEA Polynucleotides Injectable Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Polynucleotides Injectable Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Polynucleotides Injectable Price by Application (2021-2032)
  9. 12.3 SAMEA Polynucleotides Injectable Market Size by Country
  10. 12.3.1 SAMEA Polynucleotides Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Polynucleotides Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Polynucleotides Injectable Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Polynucleotides Injectable Value Chain Analysis
  2. 13.1.1 Polynucleotides Injectable Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Polynucleotides Injectable Production Mode & Process
  6. 13.2 Polynucleotides Injectable Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Polynucleotides Injectable Distributors
  9. 13.2.3 Polynucleotides Injectable Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst